Evidence map›Paper›PMID 40670484›Full record

ArticleScientific reports2025

Size reduction of selenium nanoparticles synthesized from yeast beta glucan using cold atmospheric plasma.

Berat Cinar-Acar

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Berat Cinar-AcarFaculty of Science, Department of Biology, Gazi University, 906500, Ankara, Turkey. beratcinar@gazi.edu.tr.ORCID http://orcid.org/0000-0003-4662-0865

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The limitations of both inorganic and organic selenium sources, such as low bioavailability and potential toxicity, have driven research towards selenium nanoparticles (SeNPs). In this study, β-glucan was extracted from the cell wall of Kluyveromyces marxianus M59 and subsequently carboxymethylated to enhance its water solubility. Carboxymethylated β-glucan was then utilized for the synthesis of selenium nanoparticles (SeNPs), and their sizes were determined using Scanning Electron Microscopy (SEM) analysis. To reduce the size of larger nanoparticles, Cold Atmospheric Plasma (CAP) treatment was applied, resulting in an approximately 82.4% decrease in particle size. The SeNPs obtained ranged in size from 180 to 83 nm. The synthesized SeNPs were characterized using UV-Vis Spectrophotometry, Fourier-Transform Infrared Spectroscopy (FTIR), and X-ray Diffraction (XRD) analysis. The absorption peak of SeNPs was detected at 330 nm, further confirming their amorphous nature. Additionally, the biological activities of SeNPs, including their antimicrobial, antibiofilm, and antioxidant properties, were investigated. When the antibiofilm activity of SeNPs was evaluated, the highest inhibition rate (43.6 ± 0.1%) was observed at a concentration of 5 mg/mL. In contrast, regarding antimicrobial activity, SeNPs exhibited limited inhibition zones at low concentrations, with a maximum inhibition diameter of 1.20 mm recorded. Antioxidant activity was evaluated through 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging, superoxide anion scavenging, and hydroxyl radical scavenging assays. The highest antioxidant activity was determined at 5 mg/mL SeNP concentration (47.7%) at DPPH method. The cytotoxic effects of SeNPs were evaluated on both healthy (L929) and lung cancer (A549) cell lines. The IC

Indexed as

beta-GlucansMetal NanoparticlesNanoparticlesPlasma GasesSeleniumAntioxidantsBiofilmsHumansParticle SizeSpectroscopy, Fourier Transform InfraredX-Ray DiffractionAntioxidantsbeta-GlucansPlasma GasesSeleniumBeta-glucanBiological activityCharacterizationCold atmospheric plasmaCytotoxicityKluyveromyces marxianusSelenium nanoparticles

Identifiers

PMID40670484
PMCPMC12267570

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.